Vanguard Group Inc Harmony Biosciences Holdings, Inc. Transaction History

Vanguard Group Inc

$4.96 Trillion
Q1 2024

A detailed history of Vanguard Group Inc transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 3,628,225 shares of HRMY stock, worth $109 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,628,225

Previous 3,674,764 1.27%

Holding current value

$109 Million

Previous $119 Million 2.65%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$29.93 - $35.06 $1.39 Million - $1.63 Million	-46,539 Reduced 1.27%	3,628,225 $122 Million
Q4 2023 Feb 14, 2024	SELL	$19.2 - $33.78 $180,249 - $317,126	-9,388 Reduced 0.25%	3,674,764 $119 Million
Q3 2023 Nov 14, 2023	BUY	$31.89 - $39.03 $2.82 Million - $3.45 Million	88,295 Added 2.46%	3,684,152 $121 Million
Q2 2023 Aug 14, 2023	BUY	$30.5 - $37.4 $1.85 Million - $2.27 Million	60,572 Added 1.71%	3,595,857 $127 Million
Q1 2023 May 15, 2023	BUY	$30.8 - $53.92 $8.64 Million - $15.1 Million	280,644 Added 8.62%	3,535,285 $115 Million

Q4 2022 Feb 10, 2023	BUY	$45.4 - $60.91 $11.4 Million - $15.3 Million	251,185 Added 8.36%	3,254,641 $179 Million
Q3 2022 Nov 14, 2022	BUY	$42.06 - $55.45 $1.64 Million - $2.16 Million	38,958 Added 1.31%	3,003,456 $133 Million
Q2 2022 Aug 12, 2022	BUY	$33.54 - $52.15 $8.79 Million - $13.7 Million	261,985 Added 9.69%	2,964,498 $145 Million
Q1 2022 May 13, 2022	BUY	$33.14 - $51.13 $1.44 Million - $2.22 Million	43,428 Added 1.63%	2,702,513 $131 Million
Q4 2021 Feb 14, 2022	SELL	$34.09 - $43.91 $15 Million - $19.4 Million	-440,856 Reduced 14.22%	2,659,085 $113 Million
Q3 2021 Nov 12, 2021	BUY	$25.68 - $38.61 $49.8 Million - $74.8 Million	1,938,066 Added 166.81%	3,099,941 $119 Million
Q2 2021 Aug 13, 2021	BUY	$25.96 - $33.44 $30.2 Million - $38.9 Million	1,161,875 New	1,161,875 $32.8 Million

Others Institutions Holding HRMY

# of Institutions

213

Shares Held

44M

Call Options Held

68.4K

Put Options Held

52.1K

View Full List

About Harmony Biosciences Holdings, Inc.

Ticker HRMY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,161,400
Market Cap $1.78B
Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...

More about HRMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Harmony Biosciences Holdings, Inc. Transaction History